Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure Francisco J. Blanco; Esteban Rubio-Romero; Raimon Sanmartí; César Díaz-Torné; Pablo Talavera; Jochen Dunkel; Esperanza Naredo;

Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023 Carlos Abud-Mendoza; Francisco Javier Aceves-Ávila; César Alejandro Arce-Salinas; José Álvarez Nemegyei; Leonor Barile-Fabris; Sergio Durán-Barragán; Diana Elsa Flores-Alvarado; Eufrates Hernández-Núñez; Fedra Irazoque-Palazuelos; José Francisco Moctezuma-Ríos; Virginia Pascual-Ramos; Margarita Portela-Hernández; Luis Humberto Silveira; Lilia Andrade-Ortega; Ana Barrera-Vargas; Sandra Carrillo-Vázquez; Zully Castro-Colin; Enrique Cuevas-Orta; Luis Felipe Flores-Suárez; Guillermo Arturo Guaracha-Basáñez; María Fernanda Hernández-Cabrera; Iván de Jesús Hernández-Galarza; David Alejandro Herrera-vanOostdam; Adriana Concepción Lobato-Belmonte; Laura Aline Martínez-Martínez; Marco Ulises Martínez-Martínez; Gabriel Medrano-Ramírez; Francisco Javier Merayo-Chalico; Graciela Meza-López y Olguín; Francisco Olan; Genaro Peña-Santos; César Ramos-Remus; Greta Reyes-Cordero; Vijaya Rivera-Terán; Jorge Rojas-Serrano; Griselda Serna-Peña; Sandra Sicsik-Ayala; César Armando Sifuentes-Cantú; David Vega-Morales; Pablo Villaseñor-Ovies; Daniel Xibillé-Friedmann; César Pacheco-Tena;

JAK kinase inhibitors and varicella zoster virus infection in patients with rheumatoid arthritis. Systematic review of the literature Carmen Olga Sánchez González; Juan Carlos Nieto González;